These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6095344)

  • 41. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential inhibition by propranolol of feeding induced in rats by various stimuli.
    Bryant HU; Malven PV; Yim GK
    Pharmacol Biochem Behav; 1984 Oct; 21(4):651-4. PubMed ID: 6095326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination of butorphanol and nalbuphine in opioid-dependent humans.
    Preston KL; Bigelow GE; Liebson IA
    Pharmacol Biochem Behav; 1990 Nov; 37(3):511-22. PubMed ID: 1708145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
    Shearman GT; Stenfors C
    Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diversified electrophysiological properties of morphinan drugs in rats.
    Sagratella S; Zeng YC; Frank C; de Carolis AS
    Gen Pharmacol; 1991; 22(2):231-6. PubMed ID: 1647341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opiate control of spontaneous locomotor activity in a urodele amphibian.
    Deviche P; Lowry CA; Moore FL
    Pharmacol Biochem Behav; 1989 Dec; 34(4):753-7. PubMed ID: 2560213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actions of kappa, sigma and partial mu narcotic receptor agonists on rat brain acetylcholine turnover.
    Wood PL; Rackham A
    Neurosci Lett; 1981 Apr; 23(1):75-80. PubMed ID: 6262686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions among aging, gender, and gonadectomy effects upon naloxone hypophagia in rats.
    Islam AK; Beczkowska IW; Bodnar RJ
    Physiol Behav; 1993 Nov; 54(5):981-92. PubMed ID: 8248393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of naloxone and diprenorphine on spontaneous activity in rats and mice.
    DeRossett SE; Holtzman SG
    Pharmacol Biochem Behav; 1982 Aug; 17(2):347-51. PubMed ID: 7134243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of opioid receptor subtypes in rat feeding behavior.
    Simone DA; Bodnar RJ; Goldman EJ; Pasternak GW
    Life Sci; 1985 Mar; 36(9):829-33. PubMed ID: 2983173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An animal model of bulimia nervosa: opioid sensitivity to fasting episodes.
    Hagan MM; Moss DE
    Pharmacol Biochem Behav; 1991 Jun; 39(2):421-2. PubMed ID: 1946582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kappa receptors mediate the peripheral aversive effects of opiates.
    Bechara A; van der Kooy D
    Pharmacol Biochem Behav; 1987 Oct; 28(2):227-33. PubMed ID: 2825221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of deprivation-induced food intake by D-phenylalanine.
    Bodnar RJ; Butler PD
    Int J Neurosci; 1983 Sep; 20(3-4):295-30. PubMed ID: 6321375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the opioid activity of CAM and kappa agonists.
    Furst S; Friedmann T; Kovacs A; Wagner T
    NIDA Res Monogr; 1986; 75():224-7. PubMed ID: 2828975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of opiate agonists-antagonists on morphine-induced hyperexcitability and analgesia in mice.
    Filibeck U; Castellano C; Oliverio A
    Psychopharmacology (Berl); 1981; 73(2):134-6. PubMed ID: 6785803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.